Peter Hallerback, Business Unit Director, General Medicine at Amgen

Peter Hallerback

Business Unit Director, General Medicine at Amgen | Stockholm, Stockholm County, Sweden

Profile last verified July 2026
Biotechnology Verified Profile Stockholm, Stockholm County, Sweden Mälardalen University
Verified

Work Email

***@telia.com

Last verified May 2026

Phone Number

+46*****

Sweden • Mobile

Free account · No credit card · 5 profiles/month

Peter Hallerback Socials
Peter Hallerback Work Experience

Business Unit Director, General Medicine at Amgen in January 2020 - Present

Commercial Director Western & Southern Europe at AstraZeneca in May 2018 - January 2020

Commercial Director Oncology at AstraZeneca in April 2016 - May 2018

See more See less

Head of Moventig Task Force at AstraZeneca in September 2015 - March 2016

Global Brand Director, Infection at AstraZeneca in September 2012 - August 2015

Therapy Area Director, Diabetes at AstraZeneca Nordic in August 2009 - September 2012

Therapy Area Director, Cardiovascular at AstraZeneca in October 2008 - August 2009

Business Unit Director, Neuroscience at AstraZeneca in June 2007 - September 2008

Brand Manager, Respiratory at AstraZeneca in May 2003 - May 2007

Regional Brand Manager, Respiratory at AstraZeneca in June 2002 - May 2003

Regional Sales Manager, Respiratory at AstraZeneca in August 2000 - June 2002

Peter Hallerback Education

Mälardalen University, Bachelor of Economics, August 1993 to August 1996

Peter Hallerback Skills
Brand Management Diabetes Early Adopter Global Marketing International Marketing Management Market Access Marketing Pharmaceutical Industry Pharmaceutical Sales Public Relations Sales Sales Effectiveness Sales Management Strategic Communications Strategic Planning Strategy Business Strategy Cross-functional Team Leadership
About Peter Hallerback’s Current Company
Amgen

Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We helped establish the biotechnology industry, and we remain on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today. Our investment in research and development has yielded a robust pipeline that builds on our existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases. Amgen is one of 30 companies comprising the Dow Jones Industrial Average®, and part of the Nasdaq-100 Index®. In 2024, Amgen was named one of the “World’s Most Innovative Companies” by Fast Company and one of “America’s Best Large Employers” by Forbes. For more information, visit Amgen.com and follow us on X, LinkedIn, Instagram, TikTok, YouTube and Threads. 🔗 Community Guidelines: https://wwwext.amgen.com/community-guidelines 🔗Global Privacy Statement Directory: www.amgen.com/dp Special Advisory: Please be cautious of scam recruitment offers claiming to be from Amgen. Such scams may come from various sources, including fake websites and/or unsolicited emails and seek to obtain personal data or payment from victims by offering jobs that do not exist. Please be advised that Amgen would never ask for payment to progress a job application. When in doubt, please check to see if the position in question is posted on this website before applying. Additionally, please report any suspicious recruiting activity to https://complaint.ic3.gov/ and thank you for your assistance.

Discover more about Amgen
Peter Hallerback’s Colleagues
Vladimiro Ruiz

Vladimiro Ruiz

Sangenjo, Galicia, Spain

Apasionado por la innovación y creatividad dentro del mundo comercial en el sector farmacéutico, curioso por naturaleza, buscando ser cada día mejor profesional y, sobretodo, mejor persona.

Sr.Biopharmaceutical Rep CardioRenal at Amgen
(May 2025 – Present)

Victor Ortizmorales

Victor Ortizmorales

Puerto Rico

Quality Assurance

Senior Quality Assurance Associate at Amgen
(September 2025 – Present)

Merveille Eguida

Merveille Eguida

Copenhagen, Capital Region of Denmark, Denmark

R&D PostDoc at Amgen | Computational Drug Design | Ultra-large Screening | DNA-Encoded Libraries

Postdoctoral Fellow, Computational Drug Design at Amgen
(October 2023 – Present)

Helena Aguas

Helena Aguas

Barcelona, Catalonia, Spain

Business Analysis & Insights Manager | Sales Forecasting | Brand Performance Trackers | Market Research Projects | Commercial Insights | ELMAC Region

Business Analysis & Insights Manager ELMAC Region at Amgen
(October 2024 – Present)

Raquel Quental

Raquel Quental

Portugal

Senior Manager Quality Compliance

Senior Manager Quality Compliance at Amgen
(April 2025 – Present)

Ipek Senturan

Ipek Senturan

Türkiye

Private Market Business Unit Manager & Immunology Marketing Manager at Amgen

Private Market Business Unit Manager & Immunology Marketing Manager at Amgen
(January 2024 – Present)

Search similar profiles
Frequently asked questions about Peter Hallerback

What is Peter Hallerback email address?

Email Peter Hallerback at [email protected] and [email protected]. This email is the most updated Peter Hallerback's email found in 2026.

What is Peter Hallerback phone number?

Peter Hallerback phone number is +46722407382.

How to contact Peter Hallerback?

To contact Peter Hallerback send an email to [email protected] or [email protected]. If you want to call Peter Hallerback try calling on +46722407382. (updated on November 30, 2025)

What company does Peter Hallerback work for?

Peter Hallerback works for Amgen.

What is Peter Hallerback's role at Amgen?

Peter Hallerback is Business Unit Director, General Medicine

What industry does Peter Hallerback work in?

Peter Hallerback works in the Biotechnology industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free